Puma Biotechnology Lands $5,000,000 New Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6358530e-ab65-46fd-be00-ff4f9acee570&Preview=1
Date
11/23/2011
Company Name
Puma Biotechnology
Mailing Address
10940 Wilshire Blvd Los Angeles, CA 90024
Company Description
Puma Biotechnology, Inc. is a development-stage biopharmaceutical company dedicated to in-licensing and developing novel therapeutics for the treatment of cancer.
Website
http://www.pumabiotechnology.com
Transaction Type
Venture Equity
Transaction Amount
$5,000,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds from the financing will be used primarily to fund the continued clinical development of PB-272 (oral neratinib).
M&A Terms
Venture Investor
Undisclosed